AGE-RELATED MACULAR DEGENERATION (ARMD)
Clinical trials for AGE-RELATED MACULAR DEGENERATION (ARMD) explained in plain language.
Never miss a new study
Get alerted when new AGE-RELATED MACULAR DEGENERATION (ARMD) trials appear
Sign up with your email to follow new studies for AGE-RELATED MACULAR DEGENERATION (ARMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut-Brain-Eye link? supplement shows promise for dry eye relief
Symptom relief CompletedThis study tested whether a dietary supplement could improve dry eye symptoms by changing the bacteria in the gut. Twenty adults with dry eye disease took the supplement for 8 weeks. Researchers measured tear production and eye surface health at the start and end of the study. Th…
Matched conditions: AGE-RELATED MACULAR DEGENERATION (ARMD)
Phase: NA • Sponsor: Varol TUNALI • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC
-
Eye injection study reveals which patients feel the most strain
Knowledge-focused CompletedThis study looked at how much of a burden patients feel from repeated eye injections for three different eye diseases: wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Researchers interviewed 393 patients about their treatment experience, …
Matched conditions: AGE-RELATED MACULAR DEGENERATION (ARMD)
Sponsor: Hospital Hietzing • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC